Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 3
1971 1
1972 2
1982 1
1984 3
1985 6
1987 4
1988 3
1989 9
1990 6
1991 12
1992 6
1993 14
1994 17
1995 28
1996 34
1997 31
1998 48
1999 49
2000 57
2001 71
2002 95
2003 108
2004 162
2005 177
2006 184
2007 248
2008 279
2009 337
2010 391
2011 449
2012 517
2013 590
2014 605
2015 708
2016 715
2017 667
2018 763
2019 759
2020 886
2021 959
2022 855
2023 808
2024 435

Text availability

Article attribute

Article type

Publication date

Search Results

10,631 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. Among authors: ahn js. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage.
Yoon JH, Jin H, Kim HJ, Hong SP, Yang MJ, Ahn JH, Kim YC, Seo J, Lee Y, McDonald DM, Davis MJ, Koh GY. Yoon JH, et al. Among authors: ahn jh. Nature. 2024 Jan;625(7996):768-777. doi: 10.1038/s41586-023-06899-4. Epub 2024 Jan 10. Nature. 2024. PMID: 38200313 Free PMC article.
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
Park SJ, Ahn JM, Kang DY, Yun SC, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao HL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang KY, Chae JK, Smyth D, Mintz GS, Stone GW, Park DW; PREVENT Investigators. Park SJ, et al. Among authors: ahn jm. Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8. Lancet. 2024. PMID: 38604213 Clinical Trial.
Reply by Authors.
Meier KM, Mata C, Kaar JL, Rensing AJ, Dudley AG, Carrasco A Jr, Drzewiecki BA, VanderBrink BA, Streur CS, Bagli DJ, Chalmers DJ, Wilcox DT, Yerkes EB, Lau GA, Vricella GJ, Hecht SL, Copp HL, Pohl HG, Franco I, Ahn J, Wiener JS, Singer JS, Long CJ, Keays MA, Daugherty MR, Fuchs ME, Austin PF, Wu CQ, Zee RS, Misseri R, Tanaka ST, Bauer SB, Rove KO. Meier KM, et al. Among authors: ahn j. J Urol. 2024 Jul;212(1):175-176. doi: 10.1097/JU.0000000000004034. Epub 2024 May 14. J Urol. 2024. PMID: 38743826 No abstract available.
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Lim SM, Peters S, Ortega Granados AL, Pinto GDJ, Fuentes CS, Lo Russo G, Schenker M, Ahn JS, Reck M, Szijgyarto Z, Huseinovic N, Zografos E, Buss E, Stjepanovic N, O'Donnell S, de Marinis F. Lim SM, et al. Among authors: ahn js. Nat Commun. 2023 Nov 11;14(1):7301. doi: 10.1038/s41467-023-42900-4. Nat Commun. 2023. PMID: 37951954 Free PMC article. Clinical Trial.
Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
Kim MC, Lim Y, Lee SH, Shin Y, Ahn JH, Hyun DY, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Jung YH, Jeong IS, Ahn Y. Kim MC, et al. Among authors: ahn jh. Circulation. 2023 Nov 14;148(20):1570-1581. doi: 10.1161/CIRCULATIONAHA.123.066179. Epub 2023 Oct 18. Circulation. 2023. PMID: 37850383 Clinical Trial.
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Takahashi M, Cortés J, Dent R, Pusztai L, McArthur H, Kümmel S, Denkert C, Park YH, Im SA, Ahn JH, Mukai H, Huang CS, Chen SC, Kim MH, Jia L, Li XT, Tryfonidis K, Karantza V, Iwata H, Schmid P. Takahashi M, et al. Among authors: ahn jh. JAMA Netw Open. 2023 Nov 1;6(11):e2342107. doi: 10.1001/jamanetworkopen.2023.42107. JAMA Netw Open. 2023. PMID: 37966841 Free PMC article. Clinical Trial.
10,631 results
You have reached the last available page of results. Please see the User Guide for more information.